Novavax
Clinical stage biotechnology company focused on treating infectious diseases using recombinant nanoparticle vaccine technology
7
Funding Rounds
$2.4b
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Br** Mo**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| St***** Er** | - | - | |
| Ja*** F. Yo*** | - | - | |
| Gr*** Al*** | - | - | linkedin twitter facebook |
| Ri***** Do***** | - | - | |
| Ra**** Ki** | - | - | |
| Ma****** G. Mc***** | - | - | |
| Mi***** A. Mc***** | - | - | |
| Da*** Mo** | - | - |
Funding
Funding series
Funding Series Analysis
The company Novavax has raised a total of $2.38b in funding over 7 rounds.
Key Insights:
- Novavax Grant (money), July 2020: $1.6b
- Novavax Private equity, June 2020: $200m
- Novavax Grant (money), May 2020: $384m
- Novavax Grant (money), March 2020: $4m
- Novavax Grant (money), September 2015: $89m
- Novavax Private equity, September 2013: $94.6m
- Novavax Venture round, June 2008: $5m
Novavax Grant (money), July 2020
$1.6b
Novavax Private equity, June 2020
$200m
Novavax Grant (money), May 2020
$384m
Novavax Grant (money), March 2020
$4m
Novavax Grant (money), September 2015
$89m
Novavax Private equity, September 2013
$94.6m
Novavax Venture round, June 2008
$5m
Industries
Novavax is active in the following industries: